-
Get to know Natasja De Landtsheer
Get to know Natasja De Landtsheer In this edition of 'Get to know TechTransfer', we introduce our committed Management Assistant Natasja De Landtsheer. Since 2017 she has been playing a crucial role in keeping our department running smoothly. -
LogiCYCLE
The ERIS team is happy to announce that prof. Imre Keseru and Philippe Lebeau, PhD senior researcher at the VUB research group MOBILISE, have been awarded an EIT URBAN MOBILITY grant (co-funded by EU) for the project LogiCYCLE. -
EUTOPIA Health: Proposal Development Workshop in Ljubljana University organized by ERIS team
The ERIS team at VUB TechTransfer is involved in EUTOPIA Health, a 5-year Horizon Europe project that aims at spearheading health-related academic excellence and innovation in Widening Countries, which typically lag behind in terms of research and innovation activities. -
ESCORT
The ERIS team is happy to announce that VUB Professor Ives Hubloue, Chairman of the Emergency and Disaster Medicine research group and Head of the Emergency Department at UZ Brussel, is part of an international consortium that has been awarded a European grant for the project ESCORT. -
FAIR
The ERIS team is happy to announce that professor dr. Paul De Hert and Júlia Zomigani Barboza,of the Vrije Universiteit Brussel, Metajuridica, Fundamental Rights Research Centre (FRC) are part of a consortium that has been awarded an EU grant for the FAIR project. -
SafeTravellers
The ERIS team is happy to announce that VUB Professor Vagelis Papakonstantinou from the Cyber & Data Security Lab (CDSL) is part of an international consortium that has been awarded an European grant for the project SafeTravellers. -
STAN4SWAP
The ERIS team is happy to announce that VUB Professor Peter Van den Bossche, from the MOBI Electromobility Research Centre, is part of an international consortium that has been awarded a European grant for the project STAN4SWAP. -
Phorwards21: Photonics from research to market: Empowering Europe’s strategic autonomy, supporting the green deal and securing resilience– Photonics21
The ERIS team is happy to announce that VUB Professor Hugo Thienpont, Director of the Brussels Photonics innovation Center B-PHOT and Vice-rector for Innovation and Valorisation, is part of an international consortium that has been awarded a European grant for the project Phorwards21. -
360 CARLA: 360 Photonics Career Launch Programs
The ERIS team is happy to announce that VUB Professor Hugo Thienpont, Vice-Rector for Innovation and Valorisation and Head of the Brussels Photonics Innovation Center B-PHOT, and his co-workers Tine De Pauw and Astghik Chalyan are part of an international consortium that has been awarded a European... -
EUTOPIA_HEALTH: Empowering Widening universities in EUTOPIA alliance to foster academic excellence in Health
The ERIS team is happy to announce that Philippe Westbroek, Coordinator of VUBTechTransfer ERIS Cell, has been awarded an EU grant as part of the consortium EUTOPIA_HEALTH... -
PLEDGE: Politics of Grievance and Democratic Governance
The ERIS team is happy to announce that VUB Professor Karen Celis, Head of the Department of Political Sciences, is part of an international consortium that has been awarded a European grant for the project PLEDGE. -
RETOOL: Strengthening democratic governance for climate transitions
The ERIS team is happy to announce that VUB Professor Sebastian Oberthür, Director of the Research Centre for Environment, Economy and Energy, is part of an international consortium that has been awarded a European grant for the project RETOOL. -
Get to know Philippe Westbroek
Introducing Philippe, the dedicated coordinator of ERIS and founding father of the MSCA-COFUND IMPACT project. -
Collibra: a story of change, continuity and navigating challenges in the tech industry
Collibra exhibited resilience and strategic brilliance in 2023, adapting to industry shifts and emphasizing sustainable growth, as CEO Felix Van de Maele discusses in De Tijd. -
VUB Spin-off Universum Digitalis spearheads digitalization of Memling masterpieces
Universum Digitalis, a VUB spin-off, has digitalized the works of Flemish primitive Hans Memling... -
Get to know Mohammad Boroun
Introducing Mohammad, our committed Business Developer specializing in European projects at VUB TechTransfer. -
IOF-TTO Flanders event: Navigating innovation and impact in a changing world
On Thursday, November 16th, the annual IOF-TTO Flanders event unfolded, providing a platform for collaboration and inspiration. -
European patent awarded for "Strain-Amplifying Transducer" - A game-changer for the industry
The European Union has recently granted a European patent to the "Strain-Amplifying Transducer," heralding a new era for the field of civil engineering and construction. -
Celebrating Hugo Thienpont and welcoming new Fellow Akira Hiruma
On October 12, we honored Hugo Thienpont for his remarkable achievements in photonics, and acknowledged our VUB fellow, Akira Hiruma... -
-
ABSCINT secures 3 million euros to revolutionize breast cancer diagnosis and treatment
This new funding will allow ABSCINT to initiate Phase II Clinical Trail for their HER2 program. -
-
Swave Photonics turn ambitions and holographs into reality
Swave Photonics have recently secured additional seed extension funding, which will enable them to unveil their HXR chip in the coming months. -
Two VUB projects were selected for funding by Innoviris for the Applied PhD call
We are thrilled to announce that 2 out of the 4 approved projects were VUB projects. -
-
VUB and UGhent spin-off BIO INX: next step in bioprinting with human ink
HU3DINKS project brings together expert companies for the development of human tissue-based inks... -
-
Video games for children with speech or language problems
VUB-imec spin-off SAY IT Labs develops advanced speech recognition technology for people with language or speech problems. -
Precirix expands clinical trial of CAM-H2 to the US with production at Evergreen
Precirix expands clinical trial of CAM-H2 to the US with production at Evergreen... -
Collibra helps Colruyt to create a centralized data catalogue
Collibra assists Colruyt Group in creating a data catalogue. -
Annual report 2022
Interested in discovering how VUB's innovative research made a difference in 2022? Come and explore the accomplishments of 2022! We had various projects in strategic and applied research, and we even launched two new spin-off companies. If you want more details, check out the full report. -
Get to know Wesley Verbeke
Introducing Wesley, our dedicated contract manager at VUB TechTransfer since 2016. -
BIO INX: New VUB and UGent spin-off
A new innovative spin-off developing bio-inks for 3D printing. BIO INX® is a new spin-off of UGent and VUB thanks to the signing of an exclusive licensing deal. This spin-off is committed to developing bio-inks to produce organs or human 'spare parts' using 3D printers. -
Job offer: spin-off coach
Join our TechTransfer team as a spin-off coach and contribute to bridging the gap between research and industry. As a spin-off coach, you will find yourself in the team op IP management and spin-off creation. -
Growing stronger: Biotalys' Evoca fungicide delivers field trial success
Field trials of Biotalys show promising results Biotalys, a spin-off of VUB, has successfully demonstrated the effectiveness of its initial protein-based fungicide through extensive field trials. -
VoxelSensors funding injection powers the future of immersive tech
Blending physical and digital world through 3D perception VoxelSensors, a Brussels-based start-up founded by VUB alumni Ward van der Tempel and Johannes Peeters, recently announced that it has raised €5 million euros in an investment round. -
Get to know Kristel Mommaerts
Introducing Kristel, our experienced Legal Counsel at VUB TechTransfer since 2005. -
Biotalys and Syngenta team up for sustainable agriculture solutions
Revolutionizing agriculture with sustainable biocontrol solutions. -
Konligo wins the Innovative Starters Awards 2022
Innoviris awards 500K euros to Brussels' most innovative ventures. For the 12th time, Innoviris granted the Innovative Starters Awards, recognizing three promising start-ups and scale-ups operating in Brussels for up to three years. -
Get to know Jessica Hekking
Get to know Jessica Hekking Introducing Jessica, our Human & Social Sciences Valorisation Advisor at TechTransfer. She is the expert you can count on for any queries regarding opportunities, networking, proposal writing and more, in the field of applied research for SSHA. -
New VUB-UZ Brussel spin-off: Presscuff
Presscuff's innovative tube reduces pneumonia incidence and saves lives. -
Job offer: head of VUB Foundation & Fellowship
Are you passionate about innovation and making a difference? As Head of VUB Foundation and Fellowship at TechTransfer, you'll lead a team of 4 specialists, develop policies for raising funds and manage the network of VUB Fellows. -
Confo Therapeutics and Daiichi Sankyo team up to tackle CNS diseases
Confo Therapeutics, a spin-off from VUB, has teamed up with Daiichi Sankyo to discover and develop small molecule drugs targeting G-protein coupled receptors (GPCRs) associated with central nervous system (CNS) diseases, which are conditions that affect the brain and spinal cord. Confo T... -
Building a better future, one event at a time: Konligo’s circular approach
Konligo, a VUB spin-off, is striving to become a 100% circular company. -
Hubert Rahier recycles war debris in Ukraine
Hubert Rahier, professor of physical chemistry at the VUB Materials & Chemistry research group, has been approached by the Ukrainian company Sheldor to assist in the recycling of concrete from buildings destroyed during the Russian conflict. With the support of Dutch and Belgian partn... -
Discover our new brochure: ‘A world of difference’
Want to know how the research at the five Flemish universities improves society? And what knowledge and technology transfer looks like in practice? Our new brochure introduces you in the world of research valorisation by means of 25 striking examples! Click here to see the brochure. -
Confo Therapeutics announces global licensing agreement with Lily
Confo Therapeutics, a spin-off of VUB and VIB and a leader in the discovery of medications that target G-protein coupled receptors (GPCRs), announced a worldwide licensing agreement with Eli Lilly and Company for their clinical-stage compound CFTX-1554 and related backup compounds. &nbs... -
Get to know Mimi Deprez
Get to know Mimi Deprez We would like to introduce you to Mimi, a member of our European Research and Innovation Support (ERIS) team within VUB TechTransfer. -
Abscint, A VUB spin-off, receives allowance for U.S. patent
Abscint's patented technology paves the way for personalized diagnosis and therapy. Abscint, a VUB spin-off, has recently been granted a notice of allowance from the United States Patent and Trademark Office (USPTO) for its patent application. -
Get to know Hugo Loosvelt
Get to know Hugo Loosvelt Allow us to introduce Hugo, the IP, licensing, and spin-off manager at VUB TechTransfer. Hugo's expertise in intellectual property rights and licensing makes him a key contributor to our team's success. -
Get to know Qing Cai
Get to know Qing Cai Meet Qing, our Business Developer at VUB TechTransfer. She specializes in helping researchers turn their applied research into products or services, specifically in the Brussels area. -
Persomed develops personalized cancer vaccine
The Belgian start-up Persomed is developing a personalized cancer vaccine. Persomed was founded in 2020 in collaboration with VUB and 3 other partners. All of whom have expertise within the field of personalized immunotherapy. -
Intelligent charging of electric vehicles
VUB and Brussels startup Octave join hands in the CLEVER project to develop novel energy management systems for second-life battery energy storage system (BESS) in combination with intelligent charging of electric vehicles (EVs). CLEVER is funded by Innoviris and brings together the acade... -
Animab raises 10 mio euro
VIB-VUB spin-off Animab, which is developing a new class of orally administered antibodies for animal health, announced the successful closing of its Series A round. The proceedings will be used to bring its lead product to market and to expand the pipeline of antibody products in animal health. -
Prestigious Gabbay Award for Jan Steyaert
Jan Steyaert, director of the VIB-VUB Center for Structural Biology and professor at Vrije Universiteit Brussel (VUB), is the first Belgian scientist to receive the prestigious Jacob and Louise Gabbay Award for outstanding science with a translational character. He was nominated for the a... -
New CEO for metaverse innovator Swave, a spin-off from imec and VUB
Swave Photonics has announced that semiconductor industry veteran Mike Noonen takes the helm as CEO to lead metaverse innovator’s next stage of growth. -
Memory clinic Bru-BRAIN internationally recognised
The Memory clinic Bru-BRAIN is included in the European Alzheimer's consortium, making it internationally recognised. Bru-BRAIN is led by Sebastiaan Engelborghs, head of Neurology of UZBrussel and NEUR-o-AIMS, an IoF-funded consortium. -
Weave.ly, a VUB spin-off, completes first capital round
Weave.ly, a VUB spin-off, has completed a first capital round of € 300.000. The capital round was led by interuniversity seed and growth fund Qbic and completed by finance&invest.brussels. Weave.ly developed a pioneering no-code platform that allows for partial software... -
INSTA-MD: Inflammation-based Stratification for immune-Targeted Augmentation in Major Depressive disorder
Unfortunately, some applied research projects within the biomedical field do not reach the patient due to a lack of industrial interest. -
Prenatal valaciclovir-treatment for congenital CMV (Cytomegalovirus)
Unfortunately, some applied research projects within the biomedical field do not reach the patient due to a lack of industrial interest. -
Hugo Thienpont remains vice-rector Innovation & Industry Relations of VUB
We are very pleased that our new rector Jan Danckaert has chosen to prolong the mandate of Hugo Thienpont as vice-rector Innovation and Industry Relations, so that he can continue to pursue his policy. -
PIANISSIMO: Opioid detoxification for patients with Persistent Spinal Pain Syndrome Type II
Unfortunately, some applied research projects within the biomedical field do not reach the patient due to a lack of industrial interest. -
39M euro invested in VUB spin-off eTheRNA to boost mRNA therapeutics
mRNA leading expert Kenneth Chien and Novalis LifeSciences’ Marijn Dekkers invest in EUR 39M Series B2 financing of mRNA technology platform company eTheRNA to expand its expertise and capabilities as a one-stop service to bring RNA-based research and products from the lab to the clinic. -
ACTIVE-AGE@home: a home-based functional exercise program for community-dwelling frail older adults
Unfortunately, some applied research projects within the biomedical field do not reach the patient due to a lack of industrial interest. -
Emission-free parcel deliveries in Brussels
Over the next three years, VUB Mobilise and bpost will join forces toward a zero-carbon energy future. The goal of this project is to support bpost in the shift towards zero emission parcel deliveries in Brussels. -
Eckert & Ziegler will supply Actinium-255 to VUB spin-off Precirix
VUB spin-off Precirix, the clinical-stage biotechnology company developing precision radiopharmaceuticals in oncology, discloses that they signed an agreement with Eckert & Ziegler for the supply of Actinium-225. Actinium-225 is used as an active substance in cancer treatment. -
New VUB/imec spin-off Swave
Swave Photonics, an innovator in Holographic eXtended Reality (HXR) technology to bring the metaverse to life, announced a €7 million seed round. -
VUB archaeologists work on the coast of the future
Over the next four years, archaeologists from the Vrije Universiteit Brussel, together with a multidisciplinary team of researchers from the Flanders Marine Institute (VLIZ), the KULeuven and Hogeschool West-Vlaanderen (Howest), will investigate how the coastal landscape in and around Ostend evolved... -
VUB and VIB construct bio-incubator on VUB campus
The Vrije Universiteit Brussel (VUB) and VIB are partnering to build a bio-incubator on the VUB campus. To this end, they set up Bio Incubator Brussels bv. -
New VUB radar able to see through walls
A research team from the department ETRO-VUB led by Professor Johan Stiens and Dr Ali Pourkazemi has developed a radar that can look inside and through walls, ceilings and floors. The device will be useful for renovators or restorers of old buildings for which no detailed technical plan exists. -
Innovative and simple method for isolating allergy-causing antibodies
Researchers from the Vrije Universiteit Brussel have developed an innovative method with which IgE antibodies can be easily isolated from human blood. These antibodies play an important role in allergic diseases, such as asthma, hay fever, food allergy and anaphylaxis. -
Networking opportunity for researchers from the Social Sciences, Humanities & the Arts
Looking for collaboration in your research field? Nowadays researchers are expected to collaborate with a broad field of players: colleagues – often from different disciplines – , companies, non-profit organizations and governments. -
The VUB and Flanders Food build pilot bakery
Sourdough bread has promising health benefits because it contains higher levels of vitamins, minerals, and antioxidants. -
Job offer: knowledge valorisator at ERIS
Become part of ERIS, the European Research and Innovation Support team of VUB TechTransfer and work in a team of 4 people who carry out the i-ISO approach, to support the VUB research community in their quest for European funding for applied research. Questions about the job content... -
New VUB innovation series on Kanaal Z
We are back with a new documentary series about VUB's innovative research on Kanaal Z! Tune in every Thursday evening at 8pm. -
€1.7M for cancer research thanks to VUB legacies
More research into cancer in all its facets is and remains urgently needed. But it costs a lot. -
First ever Japan Chair in the European continent
The government of Japan establishes a Japan chair at the Centre For Security, Diplomacy And Strategy (CSDS) of the VUB Brussels School Of Governance (BSOG) . This Chair shall further promote a deeper understanding of Japanese politics and foreign policy in Europe. -
Brubotics makes the finals for the KUKA Innovation Award 2022
Kevin Langlois and Joris De Winter of the VUB Brubotics team made the finals of the KUKA Innovation Award 2022. This year, the KUKA Innovation Award is all about medicine and healthcare. -
Unique technique determines insulation level of walls
The VUB is working with a consortium of partners, including Green Energy Park vzw, on a unique technique to determine the insulation level of existing walls without demolition and demolition work. -
Women Award in Technology and Science
Women remain underrepresented in high-tech and scientific sectors, with only 29% of PhD graduates in engineering across the EU and only 10% of patent applications coming from women inventors. -
VUB scientists develop prototype to detect extraterrestrial life
There are various methods for detecting extraterrestrial life. But almost all of them come up against a fundamental question. What we call life: is it similar elsewhere in space to what we know here? -
Belgian Space Week
Space expertise at the VUB The VUB performs a lot of research in the space sector. Aurélie Bellemans, assistant professor of Applied Mechanics, tries to simplify very complicated computer models for calculating heat shields by applying artificial intelligence and machine learnin... -
Helpdesk for AI professionals
Self-learning algorithms are increasingly a part of our lives. But what decisions can these algorithms make? A simple “computer says no” without transparency or objection? -
Inter-university venture capital fund Qbic announces first close of new fund at €49M
Investing in spin-offs from world-class knowledge partners Qbic, an inter-university venture capital firm focusing on the transformation of technological breakthroughs into sustainable businesses, announces the first close of its third fund at €49M. -
Precirix raises €80M in Series B to advance its pipeline of precision radiopharmaceuticals
VUB spin-off Precirix , a clinical-stage biotechnology company developing precision radiopharmaceuticals in oncology, today announces the closing of a €80M Series B financing round led by new investors INKEF Capital, Jeito Capital and Forbion as co-leads. The company's lead product... -
European Research & Innovation Support 3.0 @VUB
The ERIS team of the VUB Vicerectorate Innovation & Industry Relations has launched its renewed strategy reinforced by a new team and textminer to better support its researchers looking for EU funding and opportunities for applied research! Check out the new webpages here -
Confo Therapeutics doses first subjects in Phase 1 clinical trial
Confo Therapeutics, VIB-VUB spin-off and leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), announced that the first subjects have been dosed in the company’s Phase 1, first-in-human trial of their clinical candidate CFTX-1554. -
VUB spin-off Lavima develops new fertility treatment
Couples unable to get pregnant naturally often resort to In Vitro Fertilisation (IVF) to fulfil their desire to have children. -
Nanobodies to target Parkinson's disease
Parkinson’s disease is the second most common neurodegenerative disorder, affecting more than 10 million people worldwide. This number is likely to increase as the population ages, and unfortunately there is no cure to date. -
Share your expertise on alternative methods to animal testing
RE-Place is a scientific project coordinated by the VUB and Sciensano that aims to collect the available expertise on alternative methods to animal testing, also known as “New Approach Methodologies (NAMs)”, in one central database. Recently, an optimized version of the online to... -
Job offer: spin-off coach
We are looking for a technology transfer officer focused on spin-off coaching.Read the job description here . Send your CV and motivation letter to hugo.loosvelt@vub.be before February 28. -
Get more out of your designs with new VUB spin-off weave.ly
Turn your designs into prototypes that are fully functional, deployable in the field and gather usability data for you … without writing a single line of code! Weave.ly enables companies to quickly create new digital products and validate their ideas before launching and thus before alloca... -
Interuniversity project uses light technology to detect and visualize cancer cells
Belgian and Polish world-renown experts and professors have teamed up in the project named “CHARMING”, an Excellence of Science project funded by the Research Foundation - Flanders that uses the latest light-based technologies to detect cancer in a very early stage. -
Brussels grants spin-off Axiles Bionics
VUB spin-off Axiles Bionics won the Innovative Starters Award 2021. With the Innovative Starters Award (ISA) programme, Innoviris annually supports ambitious start-ups & scale-ups that are striving for an effective strategic breakthrough. Axiles Bionics aims to deve... -
eTheRNA announces research agreement with Merck to access mRNA technologies
eTheRNA immunotherapies announces the start of a strategic partnership with Merck with the signing of a Research Agreement. The partnership will investigate the application of eTheRNA’s proprietary mRNA design expertise and LNP-delivery platforms to disease areas selected by Merck. -
Start-up Esobiotec pursues affordable cancer immunotherapy
The VUB is an Urban Engaged University that is firmly committed to the fight against cancer through scientific research. -
VUB scientists can re-implant previously collected testicular tissue in men after cancer treatment
The VUB research group Biology of the Testis (BITE) of Prof. Ellen Goossens (together with UZ Brussel) will be the first worldwide to re-implant previously collected testicular tissue in men, who do not produce sperm cells as a result of cancer treatment at a young age. -
Next step in corrosion prevention for cars
Nowadays new cars mainly consist of the very light metal aluminum and magnesium, which are not directly connected to corrosion. But that isn't quite right. -
VUB invests in applied research with IOF funding
The Industrial Research Fund (IOF) is an earmarked University Association Fund that is annually fed with a block grant from the Flemish Government. -
From demolition towards preservation: A paradigm shift for Brussels building sector
Why are buildings being demolished and how can we influence decision making processes of building teams? How do narratives on the city and architectural taste influence whether a building will be demolished?
Recently in the press
-
VUB Spin-off Universum Digitalis spearheads digitalization of Memling masterpieces
Universum Digitalis, a VUB spin-off, has digitalized the works of Flemish primitive Hans Memling... -
Video games for children with speech or language problems
VUB-imec spin-off SAY IT Labs develops advanced speech recognition technology for people with language or speech problems. -
Collibra helps Colruyt to create a centralized data catalogue
Collibra assists Colruyt Group in creating a data catalogue. -
BIO INX: New VUB and UGent spin-off
A new innovative spin-off developing bio-inks for 3D printing. BIO INX® is a new spin-off of UGent and VUB thanks to the signing of an exclusive licensing deal. This spin-off is committed to developing bio-inks to produce organs or human 'spare parts' using 3D printers. -
Animab raises 10 mio euro
VIB-VUB spin-off Animab, which is developing a new class of orally administered antibodies for animal health, announced the successful closing of its Series A round. The proceedings will be used to bring its lead product to market and to expand the pipeline of antibody products in animal health. -
Prestigious Gabbay Award for Jan Steyaert
Jan Steyaert, director of the VIB-VUB Center for Structural Biology and professor at Vrije Universiteit Brussel (VUB), is the first Belgian scientist to receive the prestigious Jacob and Louise Gabbay Award for outstanding science with a translational character. He was nominated for the a... -
New VUB/imec spin-off Swave
Swave Photonics, an innovator in Holographic eXtended Reality (HXR) technology to bring the metaverse to life, announced a €7 million seed round. -
VUB archaeologists work on the coast of the future
Over the next four years, archaeologists from the Vrije Universiteit Brussel, together with a multidisciplinary team of researchers from the Flanders Marine Institute (VLIZ), the KULeuven and Hogeschool West-Vlaanderen (Howest), will investigate how the coastal landscape in and around Ostend evolved... -
New VUB radar able to see through walls
A research team from the department ETRO-VUB led by Professor Johan Stiens and Dr Ali Pourkazemi has developed a radar that can look inside and through walls, ceilings and floors. The device will be useful for renovators or restorers of old buildings for which no detailed technical plan exists. -
Unique technique determines insulation level of walls
The VUB is working with a consortium of partners, including Green Energy Park vzw, on a unique technique to determine the insulation level of existing walls without demolition and demolition work. -
Precirix raises €80M in Series B to advance its pipeline of precision radiopharmaceuticals
VUB spin-off Precirix , a clinical-stage biotechnology company developing precision radiopharmaceuticals in oncology, today announces the closing of a €80M Series B financing round led by new investors INKEF Capital, Jeito Capital and Forbion as co-leads. The company's lead product... -
VUB scientists can re-implant previously collected testicular tissue in men after cancer treatment
The VUB research group Biology of the Testis (BITE) of Prof. Ellen Goossens (together with UZ Brussel) will be the first worldwide to re-implant previously collected testicular tissue in men, who do not produce sperm cells as a result of cancer treatment at a young age. -
VUB Green Energy Park and Photonics in De Standaard Innovation Special
Read the articles about the large-scale living lab Green Energy Park and the one-stop-shop for photonics in De Standaard. We teamed up with Maarten Messagie and Thierry Coosemans of the VUB research group Evergi and Nathalie Debaes of B-PHOT. -
New capital round values Collibra at $5 billion
VUB spin-off Collibra has raised $250M in a funding round led by Sequoia Capital. This makes Collibra the most valuable Belgian tech company. Collibra is an enterprising software company and a spin-off from the Laboratory for Semantic Technology and Applications Resea... -
Gold and silver mining from Brussels urban sewage
Researchers from the VUB and ULB have succeeded in extracting gold, silver and other precious materials from the Brussels sewage water. With the SUBLIMUS project they are looking for a way to do this on a large scale. The project is coordinated by Dr. -
Ursula von der Leyen visits VUB-ULB AI for the Common Good institute (FARI)
The EU Commission President Ursula von der Leyen, Federal Prime Minister Alexander De Croo and State Secretary Thomas Dermine visited BeCentral, to announce the Relance and Resiliance Plan for Belgium. They discovered the joint initiative FARI: AI for the Common Good institute. -
Extension to proven TriMix® adjuvant technology intended to boost dendritic cell activation
eTheRNA immunotherapies, a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and infectious diseases, announces the expansion of its strategic collaboration with the VUB with the signing of an exclusive license for TetraMix® , a new generation of th... -
VIB/VUB spin-off Biotalys takes step to Brussels stock exchange
Reinventing Food Protection The agrotechnology company Biotalys has decided to take the step to the Brussels stock exchange. -
AI makes wind energy cheaper and more efficient
Wind energy is an important renewable energy source, but the maintenance of wind farms is a very complex and expensive process. Reducing these costs is essential if the renewable energy from wind farms is to be truly sustainable. -
Innovative cooling clothing for Belgian athletes in Tokyo
Our Flemish top athletes are ready for the Olympic Games, partly thanks to scientific innovation When the Olympic Games take place in Tokyo this summer, temperatures above 30 degrees and humidity of more than 70% are expected. That's why we need to help them cool down before, during... -
Belgian technology doubles the chance of pregnancy via IVF
Fertiga is a spin-off company from one of the global IVF leading centers; UZ Brussel. -
PRECIRIX partners with Evergreen to develop targeted cancer therapy
VUB spin-off PRECIRIX and Evergreen Theragnostics, a radiopharmaceutical contract manufacturer, announced that they have entered into an agreement whereby Evergreen will provide US-based manufacturing for PRECIRIX’s lead product candidate, CAM-H2. CAM-H2 is being evaluated i... -
Wastewater against drought
VUB investigates whether treated wastewater via underground infiltration can help agriculture In recent years, Flanders has been confronted with long and intense periods of drought. -
New spin-off Abscint tackles diseases with molecular imaging
A new VUB spin-off named ABSCINT NV was established, based on technology developed by the joint research efforts of the teams of Prof. Dr. Tony Lahoutte and Prof. Dr. -
Collibra acquires leading provider of predictive data quality software
VUB spin-off Collibra announced the acquisition of OwlDQ, a leading provider of predictive data quality software. OwlDQ uses machine learning to detect anomalies in data, to generate data quality rules automatically and to reconcile replication errors. -
Cadence acquires VUB spin-off Numeca
NUMECA joins Cadence, leader in Intelligent System Design Cadence Design Systems, Inc. announced that it has entered into a definitive agreement to acquire NUMECA International, VUB spin-off and leader in computational fluid dynamics (CFD), mesh generation, multi-physics simulation... -
New Chief Business Officer at Precirix
VUB spin-off Precirix, a private, clinical-stage biotechnology company developing novel radiopharmaceuticals in oncology, announces the appointment of Dr. Niva Almaula, an experienced business development executive based in New York, as Chief Business Officer. In this role, Dr. -
eTheRNA and China Grand Pharma enter a strategic collaboration
VUB spin-off eTheRNA immunotherapies NV today announced it has entered into a strategic cooperation and product license agreement with China Grand Pharmaceutical & Healthcare Holdings Ltd to establish a new joint venture company, Nanjing AuroRNA Biotech Co., Ltd. -
European boost for photonics innovation
PhotonHub Europe will stimulate technological innovation of SMEs and mid-caps Photonics – the science and technology of light – is a key digital technology that is radically transforming the traditional industrial base. -
New VUB spin-off iCense studies people’s authentic emotions
Knowing what citizens and consumers really think of new measures, products or advertising is crucial for governments and businesses. But it is often difficult to find out. -
Camel-IDS announces company name change to PRECIRIX®
Camel-IDS, VUB spin-off and a private, clinical-stage biotechnology company developing novel radiopharmaceuticals in oncology, today announces the launch of a new corporate identity and company name change to PRECIRIX®, effective immediately. -
Axiles Bionics and BruBotics receive €2M R&D grant from Innoviris
One year after successfully completing a € 2.4M Series A financing round, Axiles Bionics announces a new R&D collaboration with BruBotics Research group from Vrije Universiteit Brussel to achieve its goal in developing a revolutionary next generation bionic prosthesis for lower limb amputees. -
Healthier workplaces thanks to collaborative robotics
Across Europe, 40 million workers suffer from muscle, joint and nerve pain caused by physically demanding tasks. Moreover, such musculoskeletal disorders are the cause of as many as half of all absences in companies and therefore cost a great deal of money. -
eTheRNA in the race for a coronavirus vaccine
More than 1,5 years ago, Steven Powell became the CEO of the VUB spin-off eTheRNA. -
15-minute city concept
In January, Parisian mayor Anne Hidalgo announced a plan to transform Paris into a 'Ville Du Quart D´Heure' with less traffic and more freedom. -
Nanoscale vibrations pioneering for detection of living organisms
An optical nanomotion detection method developed at Vrije Universiteit Brussel with the Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland shows that living yeast cells exhibit specific nanometre-scale cell movement. -
eTheRNA collects €34M for mRNA vaccines
VUB spin-off eTheRNA received €34 million to bankroll the development of its mRNA technologies, as well as a suite of mRNA immunotherapies for cancer and infectious diseases, including a program against SARS-CoV-2, the virus that causes COVID-19. -
Mobility after the COVID-19 crisis
The study by the MOBI research group about the mobility behavior before, during and – the perspectives on – after the lock-down in Belgium is finished. The results show that especially the bicycle, and in particular the electric bicycle, is gaining popularity. -
New laser produces world's first superchiral light
Researchers from the VUB, the University of Witwatersrand (South Africa), Harvard University (USA), the National University of Singapore (Singapore), and CNST (Italy) have developed the world's first meta-surface laser producing superchiral light. -
Corona consortium predicts spread of the virus
A group of top scientists from the universities of Hasselt, Antwerp, Ghent and Brussels have set up a corona consortium this week. -
VUB examines immune system of COVID-19 patients
Researchers from the VUB research group Neuro-Aging and Viro-Immunotherapy (NAVI) collect blood samples from COVID-19 patients to examine their immune system during and after their illness. With the extensive analyzes they want to unravel the immune responses of these patients. Prof. -
VUB pharmacists barometer
Pharmacists stand strong but Covid-19 takes its toll: 2 out of 3 pharmacy visits are coronavirus-related, but 40% not essential. -
UZ Brussel performs CT scan on all new patients
At the UZ Brussel all patients undergo a CT scan, also those who do not show symptoms of the new coronavirus and who are for regular hospitalization in the hospital. The CT scan is a good indicator of a possible infection with Covid-19. -
Snorkeling mask turned into emergency mask
Researcher Albert De Beir of research group BruBotics developed a plastic adaptor to turn a snorkelling mask into an emergency mask for medical staff. -
How does the coronavirus affect daily life?
The TOR research group has been conducting time-use research since 1982. Together with hbits, a Vrije Universiteit Brussel spin-off, TOR launches the time-use survey to map out the consequences of the corona crisis on daily life. -
VUB engineers build respirator for hospitals
If the number of covid-19 patients in Belgium continues to rise, there may be a shortage of artificial respirators. A team of engineers at Vrije Universiteit Brussel’s FabLab Brussels has therefore started building and testing a simple ventilator. -
New virtual currency and AI improve green energy supply
Today more and more companies & individuals are using solar panels. -
double pass partners with FIFA
VUB spin-off Double pass specialised in sport technical and talent development management, has been chosen as the partner to roll out FIFA’s new groundbreaking Talent Development Programme. -
Artificial Intelligence used to detect tumors
In cancer, AI has shown great promise in characterizing tumors, suggesting appropriate treatments and predicting patient survival. -
€3m for new cancer offensive
A consortium of the VUB and three Flemish companies has a budget of 3 million euros to test a new immunotherapy on patients with colon cancer. (Ex-) professor Kris Thielemans (VUB) is the scientific leader of the project. -
President of EC visits AI Experience Center
The VUB AI Experience Center is a high-tech test, demonstration and meeting environment where companies, technological entrepreneurs, researchers and policy makers can experiment with AI and work together to develop and produce technological solutions. -
Konligo raises €300k for its durable stands
In only a couple of days, the VUB spin-off Konligo that wants to revolutionise the event sector, has raised €300.000. The objective is to accelerate the development of its lightweight and transformable structures. -
VUB gaming-app helps patients with muscular disorders
“Ghostly” is an Android game for rehabilitation of patients suffering from motor and neuro-muscular disorders. -
VUB scientist develops self-healing robots
Humans and robots are increasingly working together. To make this collaboration as safe as possible for people and for the work they do, “soft robots” made of flexible and soft materials are becoming common. -
Test determines overtraining in athletes
Athletes can get overtrained. Not good for the body of course, but when are they really going too far and how bad are the consequences? The research team of Romain Meeusen of the research group MFYS has developed a test to determine who suffers from the so-called overtraining syndrome (OTS). -
New spin-off SAY IT Labs
This new VUB spin-off, in collaboration with imec, developed a video game for children who stutter. -
Persons of the year 2019
Felix Van de Maele, CEO of VUB spin-off Collibra, was named a person of the year by De Tijd. Collibra was the first belgian unicorn in 2019. The company was founded in 2008. Today it has about 600 employees in 8 offices in different countries over the world. Read more. -
The success of immunotherapy
Prof. dr. Bart Neyns and his colleagues of the Faculty of Medicine and Pharmaceutical Sciences have made remarkable strides in a new treatment of cancer whereby one's own body cells are used to attack the tumor. -
VUB and UAntwerpen join forces in Knowledge Platform Diversity, Urbanism & Citizenship
VUB and the University of Antwerp have launched the Knowledge Platform Diversity, Urbanism & Citizenship, a unique collaboration between the two universities, which will be located in Mechelen. -
Knowledge Center Data & Society
The Flemish government has established the Knowledge Center Data & Society (Kenniscentrum Data & Maatschappij). It focuses on the interplay between data, artificial intelligence and society. -
New CT-scanner at UZ Brussel
At the UZ Brussel, radiologists for patients who undergo a 3D diagnostic examination at the Emergency Department and the Intensive Care Unit have recently been using a new generation CT-scanner. Of which only three are in use worldwide. -
VUB brings us closer to new supercomputer
The Applied Physics research group of the VUB has developed a new generation of optical computers, so-called Coherent Ising machines. -
Flemish government invests in VUB researchers
In the past two decades, the number of young researchers in Flanders has increased considerably. -
Researchers mine Brussels’s sewers for gold and silver
The aim of the VUB-ULB project SUBLIMUS is to develop a cheap and green way to harvest gold and silver from the sludge residues of the sewage treatment plants of the Brussels-Capital Region. -
Fertiga closes first financing round
VUB spin-off Fertiga announces the closure of its first financing round together with Novalis Biotech Incubation and international private investors. Its product, the Corona Test was initially developed by the research team of Prof. Dr. -
Camel-IDS appoints new Chief Medical Officer
VUB spin-off Camel-IDS announced the appointment of Ruggero Della Bitta MD, PhD, as Chief Medical Officer. Read the press release. -
VUB spin-off Axiles Bionics enters the market
Axiles Bionics announces that it has successfully completed a €2.4M Series A financing round, led by its co-founders and several private investors, including VUB and ULB alumni. The spin-off develops an innovative smart robotic ankle-foot prosthesis for lower limb amputees. -
New science & technology center in the pipeline
Vicerector Hugo Thienpont will give the old school building in Oetingen a new meaning by establishing a STEAM academy (Science, Technology, Engineering, Arts and Mathematics). It will be an experience center for young and old, where science and technology are the common thread. -
VUB-VIB spin-off AgroSavfe raises €35m
AgroSavfe, a rapidly growing and transformative Crop and Food protection company developing a new generation of protein-based biocontrols to protect food from farm to fork, announced the closing of a Series C financing round. The funds will be primarily used for the development, registrat... -
World scoop in robotic surgery at UZ Brussel
In the Center for Cardiovascular Diseases at UZ Brussel, a patient with Dunbar's syndrome had surgery through robotic surgery for the first time. -
Europe invests in research into self-healing robots
Over the next three years, researchers from the VUB, University of Cambridge, École Supérieure de Physique et de Chimie Industrielles de la ville de Paris (ESPCI-Paris) and Swiss Federal Laboratories for Materials Science and Technology (Empa) will be working together with the Dutch Polymer manufact... -
Pharrowtech, an imec spin-off with contributions from VUB, raises €6m
Pharrowtech, an imec spin-off and designer of chip and antenna solutions for high-speed wireless applications has raised more than €6 million for its Seed investment round. -
Confo Therapeutics receives €1.7 million grant from VLAIO
VUB-VIB spin-off and emerging drug discovery company Confo Therapeutics has been awarded a €1.7 million grant from Flanders Innovation & Entrepreneurship (VLAIO). -
Social robot improves healthcare
The imec.icon ROBO-CURE research project, in collaboration with UZ Brussel, VUB, Cronos, QBMT, Medtronic Belgium, imec & UGent, developed a social robot that can autonomously offer better and more personalised care to patients with chronic diseases. -
VUB scientists further unravel secrets of proteins with the help of Artificial Intelligence
Proteins perform a wide variety of functions in cells through interactions with each other and many additional molecules. VUB professor dr. Wim Vranken, doctoral researcher Gabriele Orlando and Dr. -
VUB ranks 59 in Europe's Most Innovative Universities 2019
Reuters Top 100 institutions all produce original research, create useful technology and stimulate the global economy. More than 600 universities were screened. VUB Ranks 59 which is a very good result considering the size of the university. For the fourth consecutive year, KU Leuven tops the list. -
Interview with 'unicorn'-CEO Felix Van De Maele
Founder of VUB spin-off Collibra Felix Van De Maele was a guest in the studio at BRUZZ. He tells that 10 years ago the Brussels Region was the only investor that believed in his idea and that is why Brussels was and still is a very important stakeholder for the company. -
eTheRNA recruited first patient for mRNA immunotherapy
VUB spin-off eTheRNA announces the recruitment of the first patient for a collaborative TriMix-BRE study to investigate the effect of the TriMix product as neo-adjuvant treatment (treatment before planned surgery) for breast cancer patients. -
Collibra first Belgian startup valued at $1 billion
CapitalG, an investment arm of Google parent Alphabet, has led a $100 million funding round in the data technology spin-off Collibra.